Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

Lasers can help reduce skin side effects from cancer treatment.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Thoracic medial branch block may be a simpler and effective alternative to thoracic vertebroplasty for pain management.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Ultraviolet light helped hair growth more effectively than triamcinolone acetonide.

X-ray diffraction of hair might help detect breast cancer non-invasively.

Standardizing light therapy methods could improve spinal cord injury treatment.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Gamma-ray exposure can cause long-lasting damage to hair follicles, affecting hair structure and color.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

RCS-01 is safe and may help rejuvenate aging skin.

Fractional microneedle radiofrequency is a safe and effective skin treatment with minimal serious side effects.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.